| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/23/2003 | EP0550599B1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 04/23/2003 | CN1413258A Invasive bacterial vectors for expressing alphavirus replicons |
| 04/23/2003 | CN1413250A Method of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/23/2003 | CN1413241A Dry compositions containing hydrophobic amino acid |
| 04/23/2003 | CN1413211A Substituted 1,3,4-oxadiazoles and method of producing TNF-alpha levels |
| 04/23/2003 | CN1413207A 5-membered ring heterocyclic compounds with nitrogen |
| 04/23/2003 | CN1413186A Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 04/23/2003 | CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand |
| 04/23/2003 | CN1413120A Method of inactivating pathogens |
| 04/23/2003 | CN1413118A Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof |
| 04/23/2003 | CN1413113A Method of treating gastrointestinal tract disease using purinergic receptor agonists |
| 04/23/2003 | CN1413109A Substituted acylhydroxamic acids and method of reducing TNF-alpha levels |
| 04/23/2003 | CN1413105A Novel method of treatment |
| 04/23/2003 | CN1412182A Tetrahydroisoquinoline derivative with antifungal activity and its preparation method |
| 04/23/2003 | CN1411867A Chinese medicine pill preparation for preventing common cold and its preparation method |
| 04/23/2003 | CN1411866A Chinese medicine for radically-curing HIV/AIDS virus and its preparation method |
| 04/23/2003 | CN1411857A Tea oil ointment and suppository |
| 04/23/2003 | CN1411855A Kelao capsule and its preparation method |
| 04/23/2003 | CN1411852A Quick-acting liquor for curing AIDS |
| 04/23/2003 | CN1411837A Medicine for curing virus hepatitis and liver cancer |
| 04/23/2003 | CN1411835A Chinese medicine for curing chronic hepatitis |
| 04/23/2003 | CN1411833A Pure Chinese medicine preparation |
| 04/23/2003 | CN1411828A Medicine for preventing acute upper respiratory tract infection of children group |
| 04/23/2003 | CN1411809A Usage and composition of pyridine onium derivative for curing application |
| 04/23/2003 | CN1411800A Cosmetic composition and method |
| 04/23/2003 | CN1106380C New synthetic catechol derivatives, method for production and use thereof |
| 04/23/2003 | CN1106203C Chlamydia vaccine and process |
| 04/23/2003 | CN1106202C Anti-aids immunomodulator complex |
| 04/22/2003 | US6552225 Such as n-(2,3-dichloro-4-(methylaminosulphonyl)phenyl)-3,3,3-trifluoro-2-hydroxy-2 -methylpropanamide; diabetes, obesity, lactic acidaemia |
| 04/22/2003 | US6552203 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups |
| 04/22/2003 | US6552202 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/22/2003 | US6552196 Quinolone carboxylic acid derivatives |
| 04/22/2003 | US6552192 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof |
| 04/22/2003 | US6552183 Moncyclic L-nucleosides analogs |
| 04/22/2003 | US6552047 H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use |
| 04/22/2003 | US6552030 Inhibit human factor Xa; treating thrombotic activity; 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4-((2-(1,2 -dihydoxyethyl)-4-hydroxy-5-ethoxytetrahydrofuran-3-yl)oxy)-pyridin-2 -yl)oxy)4-hydroxybenzamidine |
| 04/22/2003 | US6552024 For administering agents in a dissolving film configuration; drug delivery |
| 04/22/2003 | US6552020 Compositions including antibiotics and methods for using same |
| 04/22/2003 | US6552019 Inhibitors of p38 |
| 04/22/2003 | US6551996 Super-active porcine growth hormone releasing hormone analog |
| 04/22/2003 | US6551824 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318 |
| 04/22/2003 | US6551820 Transgenic plants capable of expressing immunogenic polypeptides, including hepatitis B antigen (HBsAg) in quantities sufficient to elicit an immune response in a human or animal that consumes all or a part of the plant |
| 04/22/2003 | US6551816 Enzymatic method for preparing synthesis intermediates |
| 04/22/2003 | US6551811 Protein comprises at least one site for N-linked glycosylation and is attached to a plasma membrane by a glycosylphosphatidylinositol radical |
| 04/22/2003 | US6551785 Determining a subject's susceptibility to or the rapidity of progression of sepsis in a subject by detecting at least one allele of an Interleukin-1 proinflammatory haplotype in a nucleic acid sample which indicates increased susceptibility |
| 04/22/2003 | US6551616 Reducing gastrointestinal adverse side effects and improving taste |
| 04/22/2003 | US6551600 Immunological adjuvant compounds compositions and methods of use thereof |
| 04/22/2003 | US6551599 Monoclonal antibodies against campylobacter jejuni and campylobacter coli outer membrane antigens |
| 04/22/2003 | US6551597 Vaccine compositions for human papillomavirus |
| 04/22/2003 | US6551596 Fractions of Chlorella extract containing polysaccharide having immunomodulating properties |
| 04/22/2003 | US6551584 Topical antibiotic composition for treatment of eye infection |
| 04/22/2003 | CA2207741C Variants of human papilloma virus antigens |
| 04/22/2003 | CA2101075C Peptides for the treatment of conditions caused by herpes virus infections |
| 04/22/2003 | CA2091678C Viral defective vaccine produced by transcomplementing cell line |
| 04/22/2003 | CA2068630C Use of protein c or activated protein c |
| 04/22/2003 | CA1341427C Variants of immunoglobulin gene superfamily member |
| 04/19/2003 | CA2361863A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 04/17/2003 | WO2003031940A2 Structural and cytoskeleton-associated proteins |
| 04/17/2003 | WO2003031939A2 Protein modification and maintenance molecules |
| 04/17/2003 | WO2003031599A2 Live attenuated salmonella strains for producing vaccines |
| 04/17/2003 | WO2003031588A2 Hepatitis c virus vaccine |
| 04/17/2003 | WO2003031477A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 04/17/2003 | WO2003031464A2 Remodeling and glycoconjugation of peptides |
| 04/17/2003 | WO2003031459A2 Modulation of the expression of genes dependent on stat-1 |
| 04/17/2003 | WO2003031458A1 Methods for synthesis of diarylmethanes |
| 04/17/2003 | WO2003031449A2 Cross-linked glycopeptide-cephalosporin antibiotics |
| 04/17/2003 | WO2003031446A1 Imidazo-pyridine derivatives for use in the treatment of herpes viral infection |
| 04/17/2003 | WO2003031443A1 Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety |
| 04/17/2003 | WO2003031442A1 Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof |
| 04/17/2003 | WO2003031441A1 Multiple action compounds |
| 04/17/2003 | WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | WO2003031431A1 Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) |
| 04/17/2003 | WO2003031413A1 Quinoline derivatives, synthesis method, and medicines containing said derivatives |
| 04/17/2003 | WO2003031407A2 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS |
| 04/17/2003 | WO2003031400A1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 04/17/2003 | WO2003031396A1 Salts of guanidine derivatives and pharmaceutical preparations consisting thereof |
| 04/17/2003 | WO2003030993A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 04/17/2003 | WO2003030953A1 Inhibition of exoprotein production using aromatic compositions |
| 04/17/2003 | WO2003030944A2 Inhibition of stat-1 |
| 04/17/2003 | WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | WO2003030934A2 Cpg formulations and related methods |
| 04/17/2003 | WO2003030931A2 Vaccine against arthropod-borne infectious diseases |
| 04/17/2003 | WO2003030929A1 Combination therapies using methyl donors or methyl donor enhancers and therapeutic agents for treatment of viral, proliferative and inflammatory diseases |
| 04/17/2003 | WO2003030923A1 Method of treating hepatitis virus infection with a multiphasic interferon delivery profile |
| 04/17/2003 | WO2003030921A1 Methods for producing agrimonia extract with improved activity against hepatitis B virus and pharmaceutical and food compositions containing said extract |
| 04/17/2003 | WO2003030919A1 Method of obtaining an extract of ginger |
| 04/17/2003 | WO2003030917A1 Bactericide for mrsa |
| 04/17/2003 | WO2003030909A1 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer |
| 04/17/2003 | WO2003030906A1 Treating infections by administration of oxazolidinones to the skin |
| 04/17/2003 | WO2003030905A1 Dihydroorotate dehydrogenase inhibitor |
| 04/17/2003 | WO2003030902A1 Imidazole derivates as anti-inflammatory agents |
| 04/17/2003 | WO2003030897A1 Pyrrolidinone derivatives |
| 04/17/2003 | WO2003030883A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 04/17/2003 | WO2003030878A2 Galenic microparticulate oral formulation |
| 04/17/2003 | WO2003030876A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 04/17/2003 | WO2003030875A1 Over-coated chewing gum formulations including tableted center |
| 04/17/2003 | WO2003030827A2 Compositions for and methods of treating and preventing sirs/sepsis |
| 04/17/2003 | WO2003030824A2 Methods and compositions for treating dermal lesions |
| 04/17/2003 | WO2003030819A2 Tetracycline derivatives and methods of use thereof |
| 04/17/2003 | WO2003030624A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |